Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (271-280 of 446) with videos related to

Pageof 45
Sort By:
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Blood|October 13, 2016
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatmentEli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilizationIvana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2018
Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple MyelomaAnkit Kansagra, Wilson I Gonsalves, Morie A Gertz, et al.
Leukemia|May 24, 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalE Muchtar, A Dispenzieri, S K Kumar, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Leukemia|July 11, 2025
Interleukin-6 is a highly prognostic biomarker for POEMS syndromeJoselle Cook, Rahma Warsame, Maryam Omar, et al.
Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Pageof 45

Showing results (271-280 of 446) with videos related to

Sort By:
Pageof 45
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Blood|October 13, 2016
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatmentEli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilizationIvana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2018
Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple MyelomaAnkit Kansagra, Wilson I Gonsalves, Morie A Gertz, et al.
Leukemia|May 24, 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalE Muchtar, A Dispenzieri, S K Kumar, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Leukemia|July 11, 2025
Interleukin-6 is a highly prognostic biomarker for POEMS syndromeJoselle Cook, Rahma Warsame, Maryam Omar, et al.
Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Pageof 45